ARCHIVES

Autologous BMT Equivalent To Allogeneic For Myeloma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Kurzrock and Ferrara Join UCSD Moores Cancer Center

January 25, 2013

NIH Accepting FIRST Applications

May 2, 1986

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues

January 3, 1975

Avastin Loses Indication for Breast Cancer

November 18, 2011

ONS Scientific Program Grows

June 20, 1980